Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solana Co Director's Dealing 2023

Aug 30, 2023

32724_dirs_2023-08-30_fe06716a-0727-44c3-a136-b50dfdf55882.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2023-08-28

Reporting Person: ANDREEFF DANE (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-28 Common Stock P 2688 $6.3684 Acquired 8774 Indirect
2023-08-28 Common Stock P 563 $6.3684 Acquired 1820 Indirect
2023-08-28 Common Stock P 1684 $6.3684 Acquired 8334 Indirect
2023-08-28 Common Stock P 143 $6.3684 Acquired 458 Indirect
2023-08-30 Common Stock P 2646 $7.6423 Acquired 11420 Indirect
2023-08-30 Common Stock P 555 $7.6423 Acquired 2375 Indirect
2023-08-30 Common Stock P 1658 $7.6423 Acquired 9992 Indirect
2023-08-30 Common Stock P 141 $7.6423 Acquired 599 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 30 Direct

Footnotes

F1: The share amount has been adjusted to reflect the reverse stock split effective on August 16, 2023 whereby each fifty shares issued and outstanding prior to the split were combined and converted into one share of common stock.

F2: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F4: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F5: The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.